Cellular labeling for nuclear magnetic resonance techniques
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 28, 2013
Grant Date -
Jan 24, 2013
app pub date -
Mar 6, 2012
filing date -
Jan 16, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This disclosure provides, in part, fluorocarbon imaging reagents and formulations for the ex vivo labeling of cells. Labeled cells may be detected in vivo or ex vivo by a nuclear magnetic resonance technique, such as magnetic resonance imaging (MRI) or magnetic resonance spectroscopy (MRS). The disclosure additionally provides methods for using the imaging reagents in a variety of clinical procedures.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully